Abstract:Sickle cell anemia (SCA) is a hereditary blood disorder characterized by the presence of abnormal hemoglobin S (HbS), resulting from a point mutation in the β-globin gene. This mutation causes RBCs to become rigid and crescent-shaped, impairing their ability to flow smoothly through blood vessels and leading to various clinical manifestations. SCA primarily affects individuals of African, Mediterranean, Middle Eastern, and Indian descent, with significant global health implications. In addition to chronic hemolytic anemia and vaso-occlusive crises, SCA patients experience heightened susceptibility to infections, which can significantly impact their quality of life and clinical outcomes. [ 1 ] The immune system's response to infections in SCA patients is complex and multifaceted. Central to this response are antigenic peptides – short sequences of amino acids derived from pathogens or altered self-proteins – that are presented on the surface of cells by major histocompatibility complex molecules. These peptides play a crucial role in activating T-cells, which are essential for orchestrating adaptive immune responses against pathogens. [ 2 ] Antigenic peptides serve as key mediators in the recognition and clearance of pathogens by the immune system. In SCA patients, the pathophysiological consequences of chronic hemolysis, functional asplenia, and ongoing inflammation create a unique immunological landscape. These factors contribute to altered antigen presentation and impaired T-cell function, compromising the ability of the immune system to effectively respond to pathogens. Consequently, SCA patients are particularly susceptible to infections caused by encapsulated bacteria such as Streptococcus pneumoniae and Haemophilus influenzae , as well as viral pathogens including influenza and parvovirus B19. [ 3 ] The global awareness of antigenic peptides in the context of SCA extends beyond immunological considerations to encompass clinical management and therapeutic strategies. Vaccination against encapsulated bacteria has proven effective in reducing infection rates among SCA patients. However, challenges persist, including vaccine efficacy in the face of altered immune responses and the need for continuous adaptation to evolving pathogen strains. Moreover, advancements in immunotherapy, including peptide-based vaccines and T-cell therapies, offer promising avenues for enhancing immune responses and mitigating infection risks in this vulnerable population. [ 4 ]

Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications

Biomechanics and biorheology of red blood cells in sickle cell anemia

Vascular pathophysiology of sickle cell disease

Sickle cell disease as a vascular disorder

End Organ Affection in Sickle Cell Disease

Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction

A Review of the Relationship between the Immune Response, Inflammation, Oxidative Stress, and the Pathogenesis of Sickle Cell Anaemia

Heme- and iron-activated macrophages in sickle cell disease: an updated perspective

Management of Acute Complications of Sickle Cell Disease

Impaired phagocytosis and oxidative respiratory burst activity in sickle cell anemia leukocytes

Advancing life: innovative approaches to enhance survival in sickle cell anemia patients

Unexpected Death of a Sickle Cell Disease Patient: A Case Report and Literature Review

Sickle Cell Disease: From Genetics to Curative Approaches

Global awareness of antigenic peptides – Unraveling the impact on sickle cell anemia patients in the presence of pathogens: A narrative review

Curative Therapies for Sickle Cell Disease

Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism

Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment

Eosinophilic dialogues: a molecular exploration of sickle cell anemia severity

Gene expression changes in sickle cell reticulocytes and their clinical associations

Potassium dynamics in sickle cell anemia: clinical implications and pathophysiological insights

Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.